Last reviewed · How we verify

NCT04150432

Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children

Completed NA Last updated 9 March 2026
What this trial tests

NA trial testing Edmon in Eye Diseases in 32 participants. Completed in 30 June 2021.

Timeline
30 October 2019
Primary endpoint
30 June 2020
30 June 2021

Quick facts

Lead sponsorOslo University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment32
Start date30 October 2019
Primary completion30 June 2020
Estimated completion30 June 2021
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Oslo University Hospital

Who can join

Adults 3 to 10, any sex, with Eye Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children due for elective eye surgery in propofol based anesthesia will be kept at steady state propofol infusion for maintenance, ventilation via endotracheal tube. Exhaled propofol will be measured continously by Edmon (R) (BBraun) monitor and compared with arterial plasma samples of propofol, drawn 3-5 times during the procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eye Diseases

Currently open trials in the same condition.

Other Oslo University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04150432.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing